Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer

References

• SiegelRLMillerKDJemalACancer statistics, 2018CA Cancer J Clin201868173029313949
   PubMed Web of Science ®Google Scholar
• LageHAn overview of cancer multidrug resistance: a still unsolved problemCell Mol Life Sci200865203145316718581055
   PubMed Web of Science ®Google Scholar
• LiWZhangHAssarafYGOvercoming ABC transporter- mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategiesDrug Resist Updat201627142927449595
   PubMed Web of Science ®Google Scholar
• MohammadISHeWYinLUnderstanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDRBiomed Pharmacother201810033534829453043
   PubMed Web of Science ®Google Scholar
• BreierAGibalovaLSeresMBarancikMSulovaZNew insight into p-glycoprotein as a drug targetAnticancer Agents Med Chem201313115917022931413
   PubMed Web of Science ®Google Scholar
• AminMLP-glycoprotein Inhibition for Optimal Drug DeliveryDrug Target Insights20137DTI.S12519DTI.S12534
   Google Scholar
• BinkhathlanZLavasanifarAP-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectivesCurr Cancer Drug Targets20131331134623030233
   PubMed Web of Science ®Google Scholar
• WangJSeebacherNShiHKanQDuanZNovel strategies to prevent the development of multidrug resistance (MDR) in cancerOncotarget2017848845598457129137448
   PubMedGoogle Scholar
• SunJXuKQiuYBufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cellsOncol Rep20173831420143028731184
   PubMed Web of Science ®Google Scholar
• TsaiSCYangJSPengSFBufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cellsInt J Oncol20124141431144222858649
   PubMed Web of Science ®Google Scholar
• YinPHLiuXQiuYYAnti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patientsAsian Pac J Cancer Prev201213115339534323317181
   PubMedGoogle Scholar
• ZhangZJYangYKWuWZBufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude miceJ Transl Med2014125724581171
   PubMed Web of Science ®Google Scholar
• YuanZTShiXJYuanYXBufalin reverses ABCB1-mediated drug resistance in colorectal cancerOncotarget2017829480124802628624793
   PubMedGoogle Scholar
• YuanZYeYGaoFChitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug releaseInt J Pharm20134461–219119823422276
   PubMedGoogle Scholar
• XueXLiangXJOvercoming drug efflux-based multidrug resistance in cancer with nanotechnologyChin J Cancer201231210010922237039
   PubMed Web of Science ®Google Scholar
• RamasamyTHaidarZSTranTHLayer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugsActa Biomater201410125116512725169256
   PubMed Web of Science ®Google Scholar
• RamasamyTRuttalaHBGuptaBSmart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive reviewJ Control Release201725825822625328472638
   PubMedGoogle Scholar
• RamasamyTRuttalaHBChitrapriyaNEngineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumorsActa Biomater2017484813114327794477
   PubMedGoogle Scholar
• HuangYZhaoYLiuFLiuSNano Traditional Chinese Medicine: Current Progresses and Future ChallengesCurr Drug Targets201516131548156225751006
   PubMed Web of Science ®Google Scholar
• HuQLiangBSunYPreparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancerInt J Nanomedicine201494035404125187707
   PubMed Web of Science ®Google Scholar
• LiuTHuangQBiodegradable brush-type copolymer modified with targeting peptide as a nanoscopic platform for targeting drug delivery to treat castration-resistant prostate cancerInt J Pharm201651121002101127521701
   PubMedGoogle Scholar
• LiuYWangPSunCBioadhesion and enhanced bioavailability by wheat germ agglutinin-grafted lipid nanoparticles for oral delivery of poorly water-soluble drug bufalinInt J Pharm20114191–226026521816211
   PubMedGoogle Scholar
• ShiXJQiuYYYuHIncreasing the anticancer performance of bufalin (BUF) by introducing an endosome-escaping polymer and tumor-targeting peptide in the design of a polymeric prodrugColloids Surf B Biointerfaces201816622423429602078
   PubMed Web of Science ®Google Scholar
• TianXYinHZhangSBufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinomaEur J Pharm Biopharm201487344545324846793
   PubMed Web of Science ®Google Scholar
• YinPWangYQiuYBufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activityInt J Nanomedicine201273961396922888239
   PubMed Web of Science ®Google Scholar
• ZhangHHuangNYangGLinQSuYBufalin-loaded bovine serum albumin nanoparticles demonstrated improved anti-tumor activity against hepatocellular carcinoma: preparation, characterization, pharmacokinetics and tissue distributionOncotarget201783813
   Google Scholar
• OerlemansCBultWBosMStormGNijsenJFHenninkWEPolymeric micelles in anticancer therapy: targeting, imaging and triggered releasePharm Res201027122569258920725771
   PubMed Web of Science ®Google Scholar
• SongYCaiHYinTPaclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatmentInt J Nanomed20181315851600
   PubMed Web of Science ®Google Scholar
• GuoYLuoJTanSOtienoBOZhangZThe applications of Vitamin E TPGS in drug deliveryEur J Pharm Sci201349217518623485439
   PubMed Web of Science ®Google Scholar
• SongJHuangHXiaZTPGS/Phospholipids Mixed Micelles for Delivery of Icariside II to Multidrug-Resistant Breast CancerIntegr Cancer Ther201615339039926293804
   PubMed Web of Science ®Google Scholar
• AssanhouAGLiWZhangLReversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatmentBiomaterials20157328429526426537
   PubMed Web of Science ®Google Scholar
• ChenWZouYZhongZHaagRCyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In VivoSmall20171361601997
   Web of Science ®Google Scholar
• WuJFengSLiuWGaoFChenYTargeting integrin-rich tumors with temoporfin-loaded vitamin-E-succinate-grafted chitosan oligosaccharide/d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles to enhance photodynamic therapy efficiencyInt J Pharm20175281–228729828606509
   PubMedGoogle Scholar
• ChenYFengSLiuWYuanZYinPGaoFVitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor TherapyMol Pharm20171441190120328212490
   PubMed Web of Science ®Google Scholar
• YuanZShiXQiuYReversal of P-gp-mediated multidrug resistance in colon cancer by cinobufaginOncol Rep20173731815182528184922
   PubMed Web of Science ®Google Scholar
• DingDWZhangYHHuangXEAnQZhangXBufalin induces mitochondrial pathway-mediated apoptosis in lung adenocarcinoma cellsAsian Pac J Cancer Prev20141523104951050025556498
   PubMedGoogle Scholar
• HsuCMTsaiYWanLTsaiFJBufalin induces G2/M phase arrest and triggers autophagy via the TNF, JNK, BECN-1 and ATG8 pathway in human hepatoma cellsInt J Oncol201343133834823677253
   PubMed Web of Science ®Google Scholar
• LiuFTongDLiHBufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathwayOncotarget2016788896890726758421
   PubMedGoogle Scholar
• MiaoQBiLLLiXAnticancer effects of bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagyInt J Mol Sci20131411370138223344047
   PubMed Web of Science ®Google Scholar
• TianXDaiSSunJBufalin Induces Mitochondria-Dependent Apoptosis in Pancreatic and Oral Cancer Cells by Downregulating hTERT Expression via Activation of the JNK/p38 PathwayEvid Based Complement Alternat Med20152015112
   Web of Science ®Google Scholar